GREENLEAF EXPANDS TEAM TO INCLUDE THREE FORMER FDA OFFICIALS
Greenleaf Health, Inc. (Greenleaf), a leading Food and Drug Administration (FDA) regulatory consulting firm, today announces the addition of three former FDA officials to our team of experts. Julia Barrett, …
Read More
VALIDANT ACQUIRES GREENLEAF HEALTH
GREENLEAF CEO – PATRICK RONAN – NAMED NEW VALIDANT CEO Validant, a leading global quality, compliance and regulatory consulting group (the Group), has acquired Greenleaf Health, Inc. (Greenleaf), a …
Read More
GREENLEAF LANDSCAPE SERIES PROVIDES EXPERT INSIGHT ON EMERGING REGULATORY TOPICS
Greenleaf Health, Inc. (Greenleaf) is expanding the firm’s advisory services portfolio to include a Regulatory Landscape Series that addresses emerging topics related to FDA regulation. Authored by the firm’s expert …
Read More
GREENLEAF PORTFOLIO NOW INCLUDES REMOTE COMPLIANCE SERVICES
Greenleaf Health expands its compliance and manufacturing portfolio to include remote quality and compliance support for clients. Entities regulated by the FDA encounter challenges on a regular basis. But no …
Read More
GREENLEAF HEALTH EXPANDS COMPLIANCE PORTFOLIO TO INCLUDE GOOD CLINICAL PRACTICE (GCP) SERVICES
WASHINGTON, D.C. – Greenleaf Health, a leading Food and Drug Administration (FDA) regulatory consulting firm, today announces that the firm has expanded its compliance and manufacturing portfolio to include Good …
Read More
GREENLEAF HEALTH & TRIO HEALTH PARTNER TO APPLY FDA-LEVEL RIGOR TO GROUNDBREAKING DATA PLATFORM
WASHINGTON, D.C, October 1, 2019— Greenleaf Health, a leading Food and Drug Administration (FDA) regulatory consulting firm, today announced it has entered into an exclusive agreement with Trio Health, a …
Read More
GREENLEAF HEALTH EXPANDS SERVICES TO SUPPORT CELL & GENE THERAPY
Karen Midthun, M.D. & John Taylor to Lead Team of Experts WASHINGTON, D.C. – Greenleaf Health, Inc., a leading Food and Drug Administration (FDA) regulatory consulting firm, today announces that …
Read More
KAREN MIDTHUN, M.D., FORMER FDA BIOLOGICS CENTER DIRECTOR, JOINS GREENLEAF HEALTH
Firm Announces Dr. Midthun as Principal, Drug and Biological Products WASHINGTON, D.C. – Greenleaf Health, Inc. (Greenleaf), a leading Food and Drug Administration (FDA or agency) regulatory consulting firm, today …
Read More
FDA COMPLIANCE EXPERT, KRISTEN GRUMET, JOINS GREENLEAF
Greenleaf Health announces that Kristen Grumet has joined the firm as Senior Vice President, Regulatory Compliance. The addition of Grumet to Greenleaf’s team of experts further enhances the firm’s expanded …
Read More
Greenleaf Expands Quality & Compliance Services
Greenleaf Health today announced the firm has expanded its portfolio of services to include comprehensive on-site compliance assessments, remediation, and inspection readiness. By expanding Greenleaf’s compliance service portfolio, the firm …
Read More
ROBERT J. MEYER, M.D. JOINS GREENLEAF HEALTH
Greenleaf Health announces that Robert (Bob) Meyer, M.D. has joined the firm as Principal, Drug and Biological Products. Dr. Meyer and Dr. John Jenkins, Principal, Drug and Biological Products, will …
Read More